To test this, we pretreated OCI-Ly1 lymphoma (target) cells with 0 or 1 mM AA and combined them with CD8+ T (effector) cells derived from healthy donors in various ratios of effector:target cells. The gene discussed is CD8A; the disease is lymphoma.